2-Aminothiazole → HCID 59732765, compound
Reaction equation
[CH3:1][CH:2]([CH3:5])[CH2:3][SH:4].F[C:7]1[CH:8]=[C:9]([CH3:16])[CH:10]=[CH:11][C:12]=1[N+:13]([O-:15])=[O:14].[CH2:17]([S:21][C:22]1[CH:28]=[C:27]([CH3:29])[CH:26]=[CH:25][C:23]=1[NH2:24])[CH:18]([CH3:20])[CH3:19].[NH2:30][C:31]1SC=[CH:34][N:35]=1>>[CH2:3]([S:4][C:7]1[CH:8]=[C:9]([CH3:16])[CH:10]=[CH:11][C:12]=1[N+:13]([O-:15])=[O:14])[CH:2]([CH3:5])[CH3:1].[CH2:17]([S:21][C:22]1[CH:28]=[C:27]([CH3:29])[CH:26]=[CH:25][C:23]=1[NH:24][C:34]([NH:35][C:31]1[S:4][CH:3]=[CH:2][N:30]=1)=[O:14])[CH:18]([CH3:20])[CH3:19]Participants
6
Procedure
3-(Isobutylsulfanyl)-4-nitrotoluene (0.75 g, 67%) was prepared from 2-methyl-propanethiol and 3-fluoro-4-nitrotoluene (0.77 g, 5.0 mmol) following the general procedure A. This was reduced to 2-isobutylsulfanyl-4-methyl-aniline (0.46 g, 63%) following general procedure B. 1-(2-Isobutylsulfanyl-4-methyl-phenyl)-3-thiazol-2-yl-urea (218 mg, 68%) was prepared from 2-isobutylsulfanyl-4-methyl-aniline (195 mg, 1.0 mmol) and 2-aminothiazole (100 mg, 1.0 mmol) following the general procedure D.
Sources & evidence
- ORD record
- ord-05fcd67f24c14ff7970d2b85df9e0d96
- Source dataset
- uspto-grants-2008_06
- Patent number
- US07384967B2
Reaction notes
Loading…